Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 18/20 | 0.83 |
| ▸ | MEN1 | O00255 | 2/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.74 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.74 |
| ▸ | HTT | P42858 | 1/20 | 0.74 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.74 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4018413 | 0.91 | HRH3 (1.00) | HRH3 | |
| SCHEMBL8026068 | 0.91 | HRH3 (1.00) | HRH3 | |
| SCHEMBL4023931 | 0.89 | HRH3 (0.85) | HRH3 | |
| SCHEMBL4020966 | 0.88 | HRH3 (1.00) | HRH3CYP2D6 | |
| SCHEMBL4023048 | 0.88 | HRH3 (1.00) | HRH3CYP2D6 | |
| SCHEMBL4021657 | 0.87 | HRH3 (0.82) | HRH3CYP2D6 | |
| SCHEMBL29761952 | 0.85 | NPSR1 (0.90) | HRH3MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL4019208 | 0.85 | HRH3 (0.82) | HRH3CYP2D6 | |
| SCHEMBL8022551 | 0.85 | HRH3 (0.82) | HRH3CYP2D6 | |
| SCHEMBL4028362 | 0.85 | HRH3 (0.82) | HRH3CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009095394-A1 | DIAZEPANES AS HISTAMINE H3 RECEPTOR ANTAGONISTS | EVOTEC NEUROSCIENCES GMBH (DE) | 2009-08-06 | — | — | WO | claimed |
| WO-2009095394-A1 | DIAZEPANES AS HISTAMINE H3 RECEPTOR ANTAGONISTS | EVOTEC NEUROSCIENCES GMBH (DE) | 2009-08-06 | — | — | WO | disclosed |